FindTrial
Sign In

The useage of Dexmedetomidine in laparoscopic pancreaticoduodenectomy

The useage of Dexmedetomidine in laparoscopic pancreaticoduodenectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017065
Enrollment
Unknown
Registered
2018-07-10
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic disease

Interventions

Case series:Dexmedetomidine

Sponsors

Guangdong Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. scheduled for laparoscopic pancreaticoduodenectomy surgery; 2. Aged from 18 to 65 years; 3. American society of anesthesiologists (ASA) classification I-III.

Exclusion criteria

Exclusion criteria: 1. inability to cooperate (e.g.mental disorder, disturbance of consciousness, mental retardation); 2. drug addiction and abuse; 3. Long-term use of steroid medicines; 4. presence of severe heart disease, or severe pulmonary disease; 5. presence of severe liver and renal insufficiency; 6. sinus bradycardia or other contradictions; 7. others.

Design outcomes

Primary

MeasureTime frame
inflammation;—

Countries

China

Contacts

Public ContactZhong Min

Department of Anesthesiology, Guangdong Province Hospital of Chinese Medicine

304637372@qq.com+86 13710011776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026